Inventor
MALLY MANUELA
CH14 patents
⚠️ This page may combine multiple inventors who share the name “MALLY MANUELA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXOSMITHKLINE BIOLOGICALS SA
7 patentsUS10940192B2Mar 9, 2021
Polysaccharide and uses thereof
GLAXOSMITHKLINE BIOLOGICALS SA11 citations91
US10441647B2Oct 15, 2019
Polysaccharide and uses thereof
GLAXOSMITHKLINE BIOLOGICALS SA13 citations89
US10583185B2Mar 10, 2020
Methods and compositions for immune protection against extra-intestinal pathogenic E. coli
GLAXOSMITHKLINE BIOLOGICALS SA12 citations81
US11738076B2Aug 29, 2023
Polysaccharide and uses thereof
GLAXOSMITHKLINE BIOLOGICALS SA2 citations70
US12214029B2Feb 4, 2025
Polysaccharide and uses thereof
GLAXOSMITHKLINE BIOLOGICALS SA0 citations59
US12076385B2Sep 3, 2024
Methods and compositions for immune protection against extra-intestinal pathogenic E. coli
GLAXOSMITHKLINE BIOLOGICALS SA0 citations57
US11484582B2Nov 1, 2022
Methods and compositions for immune protection against extra-intestinal pathogenic E. coli
GLAXOSMITHKLINE BIOLOGICALS SA0 citations57
JANSSEN PHARMACEUTICALS INC
4 patentsUS11446370B2Sep 20, 2022
Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof
JANSSEN PHARMACEUTICALS INC6 citations81
US12233121B2Feb 25, 2025
Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereof
JANSSEN PHARMACEUTICALS INC0 citations58
US11931405B2Mar 19, 2024
Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereof
JANSSEN PHARMACEUTICALS INC1 citations58
US11491220B2Nov 8, 2022
Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof
JANSSEN PHARMACEUTICALS INC0 citations58